Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS

Table of Contents

February 01, 2006; Volume 33,Issue 2
  • You have access
    When is a patient with rheumatoid arthritis at risk for cardiovascular disease?
    Patrick H Dessein and Barry I Joffe
    The Journal of Rheumatology February 1 2006, 33 (2) 201-203;
  • You have access
    Screening for pulmonary hypertension in scleroderma: how and when to look?
    Sanjay Mehta and Stephen Little
    The Journal of Rheumatology February 1 2006, 33 (2) 204-206;
  • You have access
    Marine oils for antiinflammatory effect -- time to take stock.
    Leslie G Cleland and Michael J James
    The Journal of Rheumatology February 1 2006, 33 (2) 207-209;
  • You have access
    Psoriasis, psoriatic arthritis, or psoriatic disease?
    Raffaele Scarpa, Fabio Ayala, Nicola Caporaso and Ignazio Olivieri
    The Journal of Rheumatology February 1 2006, 33 (2) 210-212;
  • You have access
    Etanercept in combination with sulfasalazine, hydroxychloroquine, or gold in the treatment of rheumatoid arthritis.
    James R O'Dell, Kara Petersen, Robert Leff, William Palmer, Eric Schned, Kent Blakely, Claire Haire and Ana Fernandez
    The Journal of Rheumatology February 1 2006, 33 (2) 213-218;
  • You have access
    Magnetic resonance imaging quantification of hand synovitis in patients with rheumatoid arthritis treated with adalimumab.
    Anastasia K Zikou, Maria I Argyropoulou, Paraskevi V Voulgari, Vassilios G Xydis, Spyros N Nikas, Stavros C Efremidis and Alexandros A Drosos
    The Journal of Rheumatology February 1 2006, 33 (2) 219-223;
  • You have access
    Single-blind randomized trial of combination antibiotic therapy in rheumatoid arthritis.
    Luke L Gompels, Angela Smith, Peter J Charles, Wendy Rogers, Joanne Soon-Shiong, Adam Mitchell, Caroline Doré, Peter W Taylor and Charles G Mackworth-Young
    The Journal of Rheumatology February 1 2006, 33 (2) 224-227;
  • You have access
    Course of patient-reported health outcomes in rheumatoid arthritis: comparison of longitudinal and cross-sectional approaches.
    Ines Rupp, Hendriek C Boshuizen, Leo D Roorda, Huibert J Dinant, Catharina E Jacobi and Geertrudis van den Bos
    The Journal of Rheumatology February 1 2006, 33 (2) 228-233;
  • You have access
    Safety and efficacy of etanercept treatment in elderly subjects with rheumatoid arthritis.
    Joan M Bathon, Roy M Fleischmann, Désirée Van der Heijde, John R Tesser, Paul M Peloso, Yun Chon and Barbara White
    The Journal of Rheumatology February 1 2006, 33 (2) 234-243;
  • You have access
    Subclinical atherosclerosis in rheumatoid arthritis in India.
    Sundeep Grover, Ramanand Prasad Sinha, Uttam Singh, Satyendra Tewari, Amita Aggarwal and Ramnath Misra
    The Journal of Rheumatology February 1 2006, 33 (2) 244-247;
  • You have access
    Patient, disease, and therapy-related factors that influence discontinuation of disease-modifying antirheumatic drugs: a population-based incidence cohort of patients with rheumatoid arthritis.
    Hilal Maradit-Kremers, Paulo J Nicola, Cynthia S Crowson, W Michael O'Fallon and Sherine E Gabriel
    The Journal of Rheumatology February 1 2006, 33 (2) 248-255;
  • You have access
    Revalidation of the original Cedars-Sinai health-related quality of life in rheumatoid arthritis questionnaire.
    Chiun-Fang Chiou, Cathy D Sherbourne, Izzy Cornelio, Deborah P Lubeck, Harold E Paulus, Michelle Dylan and Michael Weisman
    The Journal of Rheumatology February 1 2006, 33 (2) 256-262;
  • You have access
    Racial variation in clinical and immunological manifestations of systemic sclerosis.
    Paul J Nietert, Holly C Mitchell, Marcy B Bolster, Stephanie R Shaftman, Barbara C Tilley and Richard M Silver
    The Journal of Rheumatology February 1 2006, 33 (2) 263-268;
  • You have access
    Natural history of mild-moderate pulmonary hypertension and the risk factors for severe pulmonary hypertension in scleroderma.
    Betty Chang, Lionel Schachna, Barbara White, Fredrick M Wigley and Robert A Wise
    The Journal of Rheumatology February 1 2006, 33 (2) 269-274;
  • You have access
    Longitudinal analysis of serum cytokine concentrations in systemic sclerosis: association of interleukin 12 elevation with spontaneous regression of skin sclerosis.
    Takashi Matsushita, Minoru Hasegawa, Yasuhito Hamaguchi, Kazuhiko Takehara and Shinichi Sato
    The Journal of Rheumatology February 1 2006, 33 (2) 275-284;
  • You have access
    Lack of association of a functional -94ins/delATTG NFKB1 promoter polymorphism with susceptibility and clinical expression of biopsy-proven giant cell arteritis in northwest Spain.
    Javier Martin, Cristina Perez-Armengol, Jose A Miranda-Filloy, Jose R Vilchez, Miguel A Lopez-Nevot, Carlos Garcia-Porrua and Miguel A Gonzalez-Gay
    The Journal of Rheumatology February 1 2006, 33 (2) 285-288;
  • You have access
    Costs and quality of life of patients with ankylosing spondylitis in Canada.
    Gisela Kobelt, Patrik Andlin-Sobocki and Walter P Maksymowych
    The Journal of Rheumatology February 1 2006, 33 (2) 289-295;
  • You have access
    Muscarinic acetylcholine type-3 receptor desensitization due to chronic exposure to Sjögren's syndrome-associated autoantibodies.
    Seunghee Cha, Eric Singson, Janet Cornelius, Jarajapu P Yagna, Harm J Knot and Ammon B Peck
    The Journal of Rheumatology February 1 2006, 33 (2) 296-306;
  • You have access
    Subjective improvement in patients with psoriatic arthritis after short-term oral treatment with seal oil. A pilot study with double blind comparison to soy oil.
    Tor Magne Madland, Tormod Björkkjaer, Linn Anne Brunborg, Livar Fröyland, Arnold Berstad and Johan G Brun
    The Journal of Rheumatology February 1 2006, 33 (2) 307-310;
  • You have access
    Urokinase-type plasminogen activator, receptor, and inhibitor correlating with gelatinase-B (MMP-9) contribute to inflammation in gouty arthritis of the knee.
    Shu-Chen Chu, Shun-Fa Yang, Ko-Huang Lue, Yih-Shou Hsieh, Tang-Yan Hsiao and Ko-Hsiu Lu
    The Journal of Rheumatology February 1 2006, 33 (2) 311-317;
  • You have access
    The serine protease inhibitor trappin-2 is present in cartilage and synovial fluid in osteoarthritis.
    Kanyakorn Jaovisidha, Ann Etim, Koji Yamakawa, Ikuko Masuda, Claudia M Gohr, Bassam T Wakim, Nimaradee Boonapatcharoen, James Ninomiya and Ann K Rosenthal
    The Journal of Rheumatology February 1 2006, 33 (2) 318-325;
  • You have access
    Does the nature of deposited basic calcium phosphate crystals determine clinical course in calcific periarthritis of the shoulder?
    Jun'ichiro Hamada, Kazuya Tamai, Wataru Ono and Koichi Saotome
    The Journal of Rheumatology February 1 2006, 33 (2) 326-332;
  • You have access
    Adherence during an individualized home based 12-week exercise program in women with fibromyalgia.
    Patricia L Dobkin, Deborah Da Costa, Michal Abrahamowicz, Maria Dritsa, Roxane Du Berger, Mary-Ann Fitzcharles and Ilka Lowensteyn
    The Journal of Rheumatology February 1 2006, 33 (2) 333-341;
  • You have access
    Health status indicators among community-dwelling elders with arthritis: the Bambuí health and aging study.
    Gustavo Matta Machado, Sandhi M Barreto, Valéria M A Passos and Maria Fernanda Lima-Costa
    The Journal of Rheumatology February 1 2006, 33 (2) 342-347;
  • You have access
    Arthritis prevalence and symptoms among US non-veterans, veterans, and veterans receiving Department of Veterans Affairs Healthcare.
    Kelli L Dominick, Yvonne M Golightly and George L Jackson
    The Journal of Rheumatology February 1 2006, 33 (2) 348-354;
  • You have access
    Rituximab treatment for resistant antiphospholipid syndrome.
    Elyse Rubenstein, Daniel G Arkfeld, Samy Metyas, Shuntaro Shinada, Sonya Ehresmann and Howard A Liebman
    The Journal of Rheumatology February 1 2006, 33 (2) 355-357;
  • You have access
    Multifocal idiopathic fibrosclerosis: treatment of 2 cases with cyclosporine.
    Fayez Al-Harthy, John Esdaile, Kenneth W Berean and Andrew Chalmers
    The Journal of Rheumatology February 1 2006, 33 (2) 358-361;
  • You have access
    Development of polymyositis after long-standing rheumatoid arthritis.
    Sherry Rohekar and Laurence Rubin
    The Journal of Rheumatology February 1 2006, 33 (2) 362-363;
  • You have access
    Meningeal involvement in Wegener's granulomatosis.
    Ali Al Dhanhani, Robert Macaulay, Bill Maloney and John G Hanly
    The Journal of Rheumatology February 1 2006, 33 (2) 364-367;
  • You have access
    Tribute: John Francis Lydiard "Jack" Woodbury.
    John G Hanly
    The Journal of Rheumatology February 1 2006, 33 (2) 368;
  • You have access
    Dr. John Woodbury -- a personal recollection.
    David Hawkins
    The Journal of Rheumatology February 1 2006, 33 (2) 369;
  • You have access
    Should anti-tumor necrosis factor-alpha be the first therapy for rheumatoid vasculitis?
    Carlos Garcia-Porrua, Miguel A Gonzalez-Gay and Victor Quevedo
    The Journal of Rheumatology February 1 2006, 33 (2) 433;
  • You have access
    Definition of clinical differences.
    Henrica C W de Vet, Heleen Beckerman, Caroline B Terwee, Berend Terluin and Lex M Bouter
    The Journal of Rheumatology February 1 2006, 33 (2) 434;
  • You have access
    Antibodies to cyclic citrullinated peptides in psoriatic arthritis: do classification criteria affect study results?
    Antonio Marchesoni, Alfredomaria Lurati, Francesca Desiati, Valeria Rossi and Norma Battafarano
    The Journal of Rheumatology February 1 2006, 33 (2) 435;
  • You have access
    Use of statistical analysis in open extension studies.
    Yusuf Yazici and Hasan Yazici
    The Journal of Rheumatology February 1 2006, 33 (2) 437;
  • You have access
    Macrophage activation syndrome as an early presentation of Lupus.
    Liza J McCann, Nathan Hasson and Clarissa A Pilkington
    The Journal of Rheumatology February 1 2006, 33 (2) 438-440;

CRA Abstracts

  • You have access
    Canadian Rheumatology Association Meeting 2006
    The Journal of Rheumatology February 1 2006, 33 (2) 371-432;
Back to top
PreviousNext

In this issue

The Journal of Rheumatology
Vol. 33, Issue 2
1 Feb 2006
  • Table of Contents
  • Index by Author

Jump to

  • CRA Abstracts
  • Most Read
  • ​ Editor's Picks
  • E-letters
Loading
  • Effects of Bedtime Very Low Dose Cyclobenzaprine on Symptoms and Sleep Physiology in Patients with Fibromyalgia Syndrome: A Double-blind Randomized Placebo-controlled Study
  • Extravascular Necrotizing Granuloma: A Diagnostic Clue for Eosinophilic Granulomatosis With Polyangiitis
  • Immunoglobulin A Vasculitis Following COVID-19: A French Multicenter Case Series
  • Immune Response to SARS-CoV-2 Third Vaccine in Patients With Rheumatoid Arthritis Who Had No Seroconversion After Primary 2-Dose Regimen With Inactivated or Vector-Based Vaccines
  • Melorheostosis or “Dripping Candle Wax” Bone Disease
More...

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2022 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire